eli lilly phase 3 trial retatrutide said Thursday its experimental obesity drug delivered up to 28.3 percent body-weight reduction over 80 weeks in the pivotal TRIUMPH-1 trial, a result nearing the weight-loss range Eli Lilly Announces Positive Phase

Semaglutide GLP-1 injections help promote weight loss in patients struggling with type 2 diabetes and obesity

To do this, they used a group of tools known as epigenetic clocks, which estimate how quickly the body is aging by analyzing DNA methylation patterns

Tesamorelin addresses what many weight loss peptide approaches miss entirely: the deep abdominal fat that drives metabolic syndrome

It is FDA-approved, uses SNAC absorption technology, and rides on the same clinical evidence base as injectable Wegovy

Duodenal ulcers often cause burning and gnawing stomach pain

Nutritional Deficiencies: Losing weight too quickly may lead to inadequate nutrient intake, which can result in deficiencies